-
-
-
-
-
-
-
Evaxion reports 3-year melanoma vaccine data ahead of ESMO 2026
-
-
-
-
-
-
-
FDA approves Alcon eye drops for up to 12 hours of redness relief
-
-
-
-
-
-
-
Fractyl Health's Revita meets 6-month endpoint in weight study
-
-
-
-
-
-
-
Crescent Biopharma expands CR-001 trial with chemo combos
-
-
-
-
-
-
-
FDA clears Edesa Biotech IND for Phase 2 vitiligo drug study
-
-
-
-
-
-
-
Lilly's Omvoh shows composite disease control in bowel disease trials
-
-
-
-
-
-
-
Krystal Biotech reports KB113 lesion regression data in Gorlin syndrome
-
77,538 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.


